Oncopeptides AB (ONCO) — Financial Flexibility Index
Oncopeptides AB (ONCO) has a Financial Flexibility Index of -1.12x as of December 2025. Free cash flow of Skr-216.49 Million (operating CF Skr-216.49 Million minus capex Skr0.00) represents -1% of total liabilities (Skr193.73 Million). Check Oncopeptides AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncopeptides AB Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Oncopeptides AB across 12 annual periods. For the full cash flow conversion analysis, see Oncopeptides AB (ONCO) cash conversion ratio.
Annual Financial Flexibility Index for Oncopeptides AB (2014–2025)
Year-by-year free cash flow to debt coverage for Oncopeptides AB. Explore Oncopeptides AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.15x | Skr-222.88 Million | Skr-222.88 Million | Skr193.73 Million | ▲ +16.0% |
| 2024 | -1.37x | Skr-260.21 Million | Skr-260.57 Million | Skr189.91 Million | ▲ +10.9% |
| 2023 | -1.54x | Skr-279.38 Million | Skr-279.49 Million | Skr181.60 Million | ▲ +66.5% |
| 2022 | -4.59x | Skr-418.00 Million | Skr-420.51 Million | Skr91.03 Million | ▲ +30.8% |
| 2021 | -6.63x | Skr-1.52 Billion | Skr-1.52 Billion | Skr228.51 Million | ▼ -91.8% |
| 2020 | -3.46x | Skr-1.28 Billion | Skr-1.30 Billion | Skr369.86 Million | ▲ +1.2% |
| 2019 | -3.50x | Skr-687.94 Million | Skr-690.57 Million | Skr196.47 Million | ▼ -35.2% |
| 2018 | -2.59x | Skr-333.36 Million | Skr-333.73 Million | Skr128.70 Million | ▲ +40.7% |
| 2017 | -4.37x | Skr-270.02 Million | Skr-271.50 Million | Skr61.82 Million | ▼ -24.1% |
| 2016 | -3.52x | Skr-103.15 Million | Skr-104.26 Million | Skr29.30 Million | ▲ +52.3% |
| 2015 | -7.38x | Skr-51.69 Million | Skr-52.81 Million | Skr7.00 Million | ▼ -34.3% |
| 2014 | -5.50x | Skr-30.32 Million | Skr-31.44 Million | Skr5.52 Million | — |